Glenmede Trust’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $223K | Buy |
15,411
+420
| +3% | +$5.67K | ﹤0.01% | 1297 |
|
|
2026
Q1 | $208K | Buy |
14,991
+2,852
| +23% | +$39.7K | ﹤0.01% | 1297 |
|
|
2025
Q4 | $170K | Buy |
+12,139
| New | +$170K | ﹤0.01% | 1301 |
|
|
2025
Q1 | $160K | Sell |
12,166
-2,837
| -19% | -$39.1K | ﹤0.01% | 1233 |
|
|
2024
Q4 | $237K | Buy |
15,003
+1,948
| +15% | +$29.3K | ﹤0.01% | 1187 |
|
|
2024
Q3 | $207K | Buy |
+13,055
| New | +$210K | ﹤0.01% | 1219 |
|
|
2024
Q1 | – | Sell |
-15,200
| Closed | -$212K | – | 1380 |
|
|
2023
Q4 | $212K | Buy |
+15,200
| New | +$203K | ﹤0.01% | 1134 |
|
|
2020
Q4 | – | Sell |
-6,730
| Closed | -$93K | – | 2016 |
|
|
2020
Q3 | $93K | Sell |
6,730
-680
| -9% | -$8.1K | ﹤0.01% | 1189 |
|
|
2020
Q2 | $78K | Buy |
7,410
+1,230
| +20% | +$12.5K | ﹤0.01% | 1217 |
|
|
2020
Q1 | $50K | Hold |
6,180
| – | – | ﹤0.01% | 1695 |
|
|
2019
Q4 | $50K | Hold |
6,180
| – | – | ﹤0.01% | 1695 |
|
|
2019
Q3 | $46K | Buy |
6,180
+1,665
| +37% | +$12.4K | ﹤0.01% | 1694 |
|
|
2019
Q2 | $33K | Sell |
4,515
-155
| -3% | -$1.22K | ﹤0.01% | 1873 |
|
|
2019
Q1 | $37K | Sell |
4,670
-35
| -0.7% | -$266 | ﹤0.01% | 1821 |
|
|
2018
Q4 | $35K | Buy |
+4,705
| New | +$33.1K | ﹤0.01% | 1742 |
|
|
2018
Q2 | – | Sell |
-3,665
| Closed | -$27K | – | 2245 |
|
|
2018
Q1 | $27K | Hold |
3,665
| – | – | ﹤0.01% | 1847 |
|
|
2017
Q4 | $27K | Buy |
3,665
+1,345
| +58% | +$9.69K | ﹤0.01% | 1847 |
|
|
2017
Q3 | $16K | Buy |
2,320
+980
| +73% | +$7.05K | ﹤0.01% | 2040 |
|
|
2017
Q2 | $10K | Hold |
1,340
| – | – | ﹤0.01% | 2122 |
|
|
2017
Q1 | $10K | Sell |
1,340
-425
| -24% | -$3.67K | ﹤0.01% | 2122 |
|
|
2016
Q4 | $15K | Hold |
1,765
| – | – | ﹤0.01% | 1992 |
|
|
2016
Q3 | $15K | Sell |
1,765
-11,085
| -86% | -$106K | ﹤0.01% | 2021 |
|
|
2016
Q2 | $130K | Buy |
12,850
+1,800
| +16% | +$16.5K | ﹤0.01% | 1298 |
|
|
2016
Q1 | $99K | Hold |
11,050
| – | – | ﹤0.01% | 1336 |
|
|
2015
Q4 | $101K | Sell |
11,050
-615
| -5% | -$6.74K | ﹤0.01% | 1359 |
|
|
2015
Q3 | $149K | Buy |
11,665
+380
| +3% | +$4.72K | ﹤0.01% | 1262 |
|
|
2015
Q2 | $124K | Buy |
11,285
+570
| +5% | +$6.29K | ﹤0.01% | 1367 |
|
|
2015
Q1 | $122K | Hold |
10,715
| – | – | ﹤0.01% | 1413 |
|
|
2014
Q4 | $108K | Hold |
10,715
| – | – | ﹤0.01% | 1505 |
|
|
2014
Q3 | $112K | Hold |
10,715
| – | – | ﹤0.01% | 1433 |
|
|
2014
Q2 | $92K | Hold |
10,715
| – | – | ﹤0.01% | 1433 |
|
|
2014
Q1 | $94K | Hold |
10,715
| – | – | ﹤0.01% | 1437 |
|
|
2013
Q4 | $87K | Hold |
10,715
| – | – | ﹤0.01% | 1469 |
|
|
2013
Q3 | $80K | Hold |
10,715
| – | – | ﹤0.01% | 1461 |
|
|
2013
Q2 | $81K | Buy |
+10,715
| New | +$78.2K | ﹤0.01% | 1389 |
|
Other funds holding RDY
AIM
Glenmede Trust's RDY Position: Q2 2026 in Review
Glenmede Trust increased its Dr. Reddy's Laboratories (RDY) stake by 2.8% in Q2 2026, buying an estimated $5.67K and bringing the position to 15,411 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #1297.
Glenmede Trust first reported a position in RDY in Q2 2013 and has held it in 35 quarters since. The position peaked at $237K in Q4 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Glenmede Trust held 15,411 shares of Dr. Reddy's Laboratories worth $223K as of Q2 2026.
- Glenmede Trust bought 420 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $5.67K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Glenmede Trust's portfolio in Q2 2026, its #1297 holding.
- Glenmede Trust first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 35 quarters since.
- Glenmede Trust's Dr. Reddy's Laboratories position peaked at $237K in Q4 2024.
- 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.